Answers are grounded in this paper and cite their sources.
Age-related macular degeneration (AMD) is the most common cause of irreversible vision loss in developed countries among individuals aged 50 years and older. The neovascular form of late AMD affects only 10% of patients but is responsible for most cases of severe vision loss due to the disease. Despite their good results in treatment of neovascular AMD, anti-angiogenic agents can be ineffective in a subset of patients considered resistant to therapy. Several mechanisms have been proposed to explain his phenomenon and, subsequently, different management strategies are currently under investigation to improve patient outcomes with anti-angiogenic therapy.
No takes yet. Share an insight, caveat, or question.
Hamid et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: